1.png

The Infected Blood Inquiry


This week has seen publication of the long awaited Infected Blood Inquiry, which has conducted a comprehensive investigation into the catalogue of failures that led to more than 30,000 individuals being infected with blood borne viruses, including hepatitis C and HIV. More than 3000 have died of complications following these infections and countless more have suffered miserably as a consequence. The inquiry began in 2018 and has examined millions of documents and witness statements to determine the how this health disaster could have happened. The Report makes hard reading and found systemic, collective and individual failures, including evidence of institutional cover-ups at Government and NHS levels. There are many important recommendations that are vital to ensure a safe, effective and transparent practice in the NHS so it is important that all of those working in the NHS read the report and take action to implement the recommendations.

Many gastroenterologists and hepatologists will have patients under our care who acquired hepatitis (and other blood borne viruses) from infected blood and have had treatment for these infections. Our heartfelt sympathy goes out to all those who have needlessly suffered because of the failings outlined in this report.

Dr Coral Hollywood, VP Hepatology 


Prof Stuart McPherson, Deputy VP Hepatology


Dr Tim Cross, President of BASL


Get a free home test for hepatitis C here.

News Area
1.png
May 09, 2025

Congratulations to Dr Christopher Mountford; the new BSG Secretary

Congratulations to Dr Christopher Mountford, the new BSG Secretary.

News Area news and updates
BSg-logo.png
May 07, 2025

Help Shape the Future of GI Physiology – National Data Collection Open (May–June 2025)

The second National Data Collection for GI Physiology services will run from Monday 12th May to Friday 6th June 2025.

news and updates IBD News
BSg-logo.png
May 01, 2025

BSG Inflammatory Bowel Disease Surveillance Guideline 2025

Our newly updated guideline for colorectal surveillance for patients with IBD is now available, providing a comprehensive road map for evidence-based, expert management of the whole pathway to try and prevent or detect bowel cancer early for this higher risk patient group.